Wall Street Analysts Believe Enanta Pharmaceuticals (ENTA) Could Rally 44.85%: Here's is How to Trade

Shares of Enanta Pharmaceuticals (ENTA) have gained 13.7% over the past four weeks to close the last trading session at $12.13, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $17.57 indicates a potential upside of 44.9%.The mean estimate comprises seven short-term price targets with a standard deviation of $5.44. While the lowest estimate of $9.00 indicates a 25.8% decline from ...